ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Halozyme Therapeutics (HALO)

Technical Analysis Report for NASDAQ stock HALO Halozyme Therapeutics. Dated: 18 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock HALO Halozyme Therapeutics then click here. or read Experts views on Halozyme Therapeutics or Forecast & share price targets of Halozyme Therapeutics

Halozyme Therapeutics Opened at 69.25 and Closed at: 68.55, which is -0.03% of previous session's close. It moved within a range of 67.02 and 69.25
The session was a Bearish session with an average volume of 3654000, which is 57.13% of previous session's volumes.

  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
  • The stock has fallen, and its long term trend is also negative and in a downtrend.

A Golden cross was found 4 days back on long term averages

Support for tomorrow is 66.67 and resistance for tomorrow is 68.9
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 67.3, 66.04 resistance for tomorrow's hourly charts is 69.53, 70.5

10 Day SMA for Halozyme Therapeutics (HALO) is 70.25 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Halozyme Therapeutics (HALO) is 69.36 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Halozyme Therapeutics (HALO) is 67.84 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 68.8 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Halozyme Therapeutics is 69.2 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Halozyme Therapeutics is at 69.36 and 200 DMA is at 69.2, while 50 DMA and 100 DMA are at 67.84 and 68.8 respectively

Halozyme Therapeutics (HALO) moving average of 20 SMA is at 69.36 and 20 EMA is at 69.3

Halozyme Therapeutics (HALO) moving average of 50 SMA is at 67.84 and 50 EMA is at 68.42

Halozyme Therapeutics (HALO) moving average of 100 SMA is at 68.8 and 100 EMA is at 68.22

Halozyme Therapeutics (HALO) moving average of 200 SMA is at 69.2 and 200 EMA is at 67.13

Halozyme Therapeutics has performed better than Wave Life in short term. Holding Halozyme Therapeutics could be a better choice for now!

Krystal Biotech has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Krystal Biotech, about 14.37% more returns!

Halozyme Therapeutics has performed better than Lemaitre Vascular in short term. Holding Halozyme Therapeutics could be a better choice for now!

Alphatec Holdings has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Alphatec Holdings, about 7.01% more returns!

Halozyme Therapeutics has performed better than Omeros Corporation in short term. Holding Halozyme Therapeutics could be a better choice for now!

Halozyme Therapeutics has performed better than Organogenesis Holdings in short term. Holding Halozyme Therapeutics could be a better choice for now!

Halozyme Therapeutics has performed better than Coherus Biosciences in short term. Holding Halozyme Therapeutics could be a better choice for now!

Rhythm Pharmaceuticals has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 7.28% more returns!

Scynexis Inc has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Scynexis Inc, about 470.38% more returns!

Neuronetics Inc has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Neuronetics Inc, about 3.32% more returns!

Guardant Health has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Guardant Health, about 11.63% more returns!

Inmune Bio has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Inmune Bio, about 0.65% more returns!

Halozyme Therapeutics has performed better than Verastem Inc in short term. Holding Halozyme Therapeutics could be a better choice for now!

Halozyme Therapeutics Technical analysis of indicators

Price action analysis of Halozyme Therapeutics (HALO) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Halozyme Therapeutics in short term but the sell signal is initial and weak.

Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Halozyme Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 69.95 and Halozyme Therapeutics HALO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Halozyme Therapeutics HALO stock. Volume based technical analysis of Halozyme Therapeutics HALO stock is negative.

Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock HALO Halozyme Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And HALO Experts View which covers a lot of information including buying and selling signals

HALO future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Halozyme Therapeutics or View Candle Stick Charts here

Chart Halozyme Therapeutics (HALO)  Technical (Analysis) Reports Halozyme Therapeutics [

Videos related to: Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Halozyme Therapeutics (HALO)  Technical (Analysis) Reports Halozyme Therapeutics [

 

Back to top